Dr. Pang represents private equity firms and investment banks, healthcare providers and health systems, and life science companies, including pharmaceutical, medical device, and biotechnology companies, and medical suppliers on regulatory issues pertaining to fraud and abuse, self-referral and government program reimbursement compliance, and facility and provider licensing issues, including:
- Mergers and acquisitions
- Initial public offerings
- Joint ventures
- Government investigations
- Day-to-day regulatory counseling
Dr. Pang is a member of the American Health Lawyers Association, the California Society for Healthcare Attorneys, and the American Bar Association Health Law Section.